In a novel initiative by the Ministry of Public Health (MSP) and the Administration of State Health Services (ASSE) in Uruguay, public healthcare system users will soon be able to retrieve their prescribed medications from neighborhood pharmacies. This new system, set to roll out in January, will initially be implemented in Montevideo and the metropolitan area.
Ensuring Accessibility to Medications
Undersecretary of Public Health, José Luis Satdjian, highlighted the agreement on Twitter, which aims to provide an alternative for ASSE users when medications are unavailable at their healthcare center. A 'withdrawal slip' with prescription details will be generated for the patient to present at their chosen pharmacy.
Participating Pharmacies and Free Medications
Pharmacies participating in this initiative will be clearly identified and authorized to provide the medications without cost to the patient. This system is designed to offer convenience and ensure accessibility to prescribed drugs.
Pharmaceutical Companies and Climate Initiatives
In other news, pharmaceutical companies are targeting Scope 3 emissions in their path to net zero by 2050. Companies like AstraZeneca and GSK have committed to adopting climate initiatives to use 100% renewable energy and reduce their environmental impact. The challenges of reducing Scope 3 emissions include global supply chain complexities and the need for reforms in developing countries.
Automating Pharmacogenomic Testing
Xact Laboratories has partnered with a national prescription claims clearinghouse to automate the integration of pharmacogenomic testing results for healthcare insurance plan customers. This partnership aims to make evidence-based PGx guided prescribing decisions more accessible and actionable for healthcare providers, pharmacists, and patients.
Renewable Power in Healthcare
Global healthcare leaders are in advanced discussions with energy providers in China and India to scale renewable power across their supply chains, aiming to accelerate the transition to net zero health systems. This initiative is the first of its kind, involving companies from across the global healthcare sector to pioneer decarbonisation efforts in key markets for pharmaceuticals manufacturing.